Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Peptide + ciclosporin combination improves renal allograft survival and function

Nov. 14, 1997

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

Nov. 14, 1997

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

Nov. 12, 1997

LXR to commence pivotal trials with HK-Cardiosol

Nov. 10, 1997

Mechanism of action of triptolide investigated in human T-cells

Nov. 10, 1997

Confirmatory trials of Alpha-Beta's Betafectin to begin

Nov. 10, 1997

Merck to develop Vical technology for therapeutic vaccines

Nov. 7, 1997

Heat shock proteins: a new vaccine strategy

Nov. 6, 1997

New human rabies vaccine cleared in U.S.

Nov. 4, 1997

Novel class of compound enhances IFN-gamma and NT-3 activity

Nov. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...